-- ISRAEL DAYBOOK: Teva Profit Rises on Cephalon Purchase
-- B y   S h o s h a n n a   S o l o m o n   a n d   S h a r o n   W r o b e l
-- 2012-02-15T09:37:00Z
-- http://www.bloomberg.com/news/2012-02-15/israel-daybook-teva-quarterly-profit-rises-on-cephalon-purchase.html
(Corrects name of company in first paragraph.)  Teva Pharmaceutical Industries Ltd. (TEVA) 
 said fourth-quarter profit rose 23 percent, boosted by
last yearâ€™s acquisition of U.S. drugmaker Cephalon Inc.  Earnings excluding some costs climbed to $1.4 billion, or
$1.59 a share, from $1.1 billion, or $1.25, a year earlier, the
Petach Tikva, Israel-based company said in a statement today.
Profit matched the average estimate of $1.59 a share from 25
analysts surveyed by Bloomberg.  To contact the reporters on this story:
Shoshanna Solomon in  Tel Aviv  at 
 ssolomon22@bloomberg.net ;
Sharon Wrobel in Tel Aviv at 
 swrobel4@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  